Quality of life in dialysis patients. A Spanish multicentre study

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 2, 1996, Pages 125-129

  Moreno, F ^a   Lopez Gomez, J M ^b   Sanz Guajardo, D ^c   Jofre, R ^b   Valderrabano F ^b  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Anaemia; Chronic renal failure; Co morbidity; Erythropoietin; Haemoglobin; Quality of life

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; DIALYSIS; FEMALE; HEALTH STATUS; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 0029897636     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp2.125     Document Type: Conference Paper

References (13)

1. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM. ed. Evaluation of Chemotherapeutic Agents. New York Columbia University Press, New York, 1949: 191-205
2. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health-status measure. Med Care 1981; 19: 787-805
3. Hendricson WD, Russell IJ, Prihoda ThJ, Jacobson JM, Rogan A, Bishop GD. An approach to developing a valid Spanish language translation of a health-status questionnaire. Med Care 1989; 27: 959-966
4. Friedman EA. Diabetic nephropathy. In: Suky WN. Massry SG, eds. Therapy of Renal Diseases and Related Disorders, 2nd edn. Kluwer Academic Publishers, Massachusetts, 1991: 534-542
5. Hart LG, Evans RW. The functional status of ESRD patients as measured by the Sickness Impact Profile. J Chron Dis 1987; 40 (Suppl 1): 117S-130S
6. Evans R, Manninen D, Garrison L et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312: 553-559
7. Harris L, Luft F, Rudy D, Tierney W. Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis 1993; 21: 161-166
8. Evans RW, Rader B, Manninen DL and the Cooperative Multicenter EPO Clinical Trial Group. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. J Am Med Assoc 1990; 263: 825-830
9. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 1990; 300: 573-578
10. Moreno F, Aracil J, Pérez E, Valderrábano F. Improvement in the quality of life of haemodialysis patients treated with erythropoietin. A controlled study (abstract). Nephrol Dial Transplant 1992; 7: 770
11. Moreno F, Valderrábano F, Aracil FJ, Pérez R. Influence of haematocrit on quality of life of haemodialysis patients (abstract). Nephrol Dial Transplant 1994; 9: 1034
12. Nissenson AR. National Cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group. Am J Kidney Dis 1991; 18 (Suppl 1): 24-33
13. Eschbach JW. Erythropoietin: the promise and the facts. Kidney Int 1994; 45 (Suppl 44): S70-S76